1
|
Scioli G, Marinaccio L, Bauer M, Kamysz W, Parmar A, Newire E, Singh I, Stefanucci A, Mollica A. New Teixobactin Analogues with a Total Lactam Ring. ACS Med Chem Lett 2023; 14:1827-1832. [PMID: 38116416 PMCID: PMC10726481 DOI: 10.1021/acsmedchemlett.3c00435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2023] [Revised: 10/25/2023] [Accepted: 11/09/2023] [Indexed: 12/21/2023] Open
Abstract
Teixobactin is a new antibiotic peptide with strong efficacy against several Gram-positive resistant bacteria, the structure of which is extremely difficult to obtain in the laboratory via multistep conventional synthesis. To face the increasing antibiotic resistant bacteria, it is fundamental to introduce new types of antibiotics with innovative mechanisms of action without resistance; thus, many scientists are studying and developing new methods to synthesize teixobactin analogues. In this work, seven Arg10-teixobactin analogues with a total lactam ring have been prepared via solid phase peptide synthesis. In order to obtain the total lactam ring, d-Thr8 was replaced by (2R,3S)-diamino-propionic acid. To verify their antimicrobial activity and efficacy, each analogue was tested with MIC against different resistant pathogens, showing an interesting activity for Nle11 containing compounds.
Collapse
Affiliation(s)
- Giuseppe Scioli
- Department
of Pharmacy, University “G. d’Annunzio”
Chieti-Pescara, Via dei
Vestini 31, 66100 Chieti, Italy
| | - Lorenza Marinaccio
- Department
of Pharmacy, University “G. d’Annunzio”
Chieti-Pescara, Via dei
Vestini 31, 66100 Chieti, Italy
| | - Marta Bauer
- Department
of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, Poland
| | - Wojciech Kamysz
- Department
of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, Poland
| | - Anish Parmar
- Antimicrobial
Pharmacodynamics and Therapeutics, Department of Molecular and Clinical
Pharmacology, University of Liverpool, Sherrington Building, L69 3GA Liverpool, U.K.
- Department
of Chemistry, The Robert Robinson Laboratories, The University of Liverpool, L69 3BX Liverpool, United Kingdom
| | - Enas Newire
- Antimicrobial
Pharmacodynamics and Therapeutics, Department of Molecular and Clinical
Pharmacology, University of Liverpool, Sherrington Building, L69 3GA Liverpool, U.K.
- Department
of Chemistry, The Robert Robinson Laboratories, The University of Liverpool, L69 3BX Liverpool, United Kingdom
| | - Ishwar Singh
- Antimicrobial
Pharmacodynamics and Therapeutics, Department of Molecular and Clinical
Pharmacology, University of Liverpool, Sherrington Building, L69 3GA Liverpool, U.K.
- Department
of Chemistry, The Robert Robinson Laboratories, The University of Liverpool, L69 3BX Liverpool, United Kingdom
| | - Azzurra Stefanucci
- Department
of Pharmacy, University “G. d’Annunzio”
Chieti-Pescara, Via dei
Vestini 31, 66100 Chieti, Italy
| | - Adriano Mollica
- Department
of Pharmacy, University “G. d’Annunzio”
Chieti-Pescara, Via dei
Vestini 31, 66100 Chieti, Italy
| |
Collapse
|
2
|
Parmar A, Lakshminarayanan R, Iyer A, Goh ETL, To TY, Yam JKH, Yang L, Newire E, Robertson MC, Prior SH, Breukink E, Madder A, Singh I. Development of teixobactin analogues containing hydrophobic, non-proteogenic amino acids that are highly potent against multidrug-resistant bacteria and biofilms. Eur J Med Chem 2023; 261:115853. [PMID: 37857144 DOI: 10.1016/j.ejmech.2023.115853] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2023] [Revised: 09/24/2023] [Accepted: 10/01/2023] [Indexed: 10/21/2023]
Abstract
Teixobactin is a cyclic undecadepsipeptide that has shown excellent potency against multidrug-resistant pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). In this article, we present the design, synthesis, and antibacterial evaluations of 16 different teixobactin analogues. These simplified analogues contain commercially available hydrophobic, non-proteogenic amino acid residues instead of synthetically challenging expensive L-allo-enduracididine amino acid residue at position 10 together with different combinations of arginines at positions 3, 4 and 9. The new teixobactin analogues showed potent antibacterial activity against a broad panel of Gram-positive bacteria, including MRSA and VRE strains. Our work also presents the first demonstration of the potent antibiofilm activity of teixobactin analogoues against Staphylococcus species associated with serious chronic infections. Our results suggest that the use of hydrophobic, non-proteogenic amino acids at position 10 in combination with arginine at positions 3, 4 and 9 holds the key to synthesising a new generation of highly potent teixobactin analogues to tackle resistant bacterial infections and biofilms.
Collapse
Affiliation(s)
- Anish Parmar
- Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, William Henry Duncan Building, 6 West Derby St, Liverpool, L7 8TX, UK; Antimicrobial Drug Discovery and Development, Department of Chemistry, The Robert Robinson Laboratories, University of Liverpool, L69 3BX, Liverpool, UK
| | - Rajamani Lakshminarayanan
- Singapore Eye Research Institute, The Academia, Discovery Tower Level 6, 20 College Road, 169857, Singapore
| | - Abhishek Iyer
- Organic and Biomimetic Chemistry Research Group, Department of Organic and Macromolecular Chemistry, Ghent University, Krijgslaan 281 (S4), B-9000, Ghent, Belgium
| | - Eunice Tze Leng Goh
- Singapore Eye Research Institute, The Academia, Discovery Tower Level 6, 20 College Road, 169857, Singapore
| | - Tsz Ying To
- Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, William Henry Duncan Building, 6 West Derby St, Liverpool, L7 8TX, UK; Antimicrobial Drug Discovery and Development, Department of Chemistry, The Robert Robinson Laboratories, University of Liverpool, L69 3BX, Liverpool, UK
| | - Joey Kuok Hoong Yam
- Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University, 637551, Singapore
| | - Liang Yang
- Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University, 637551, Singapore; School of Biological Sciences, Division of Structural Biology and Biochemistry, Nanyang Technological University, 639798, Singapore
| | - Enas Newire
- Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, William Henry Duncan Building, 6 West Derby St, Liverpool, L7 8TX, UK; Antimicrobial Drug Discovery and Development, Department of Chemistry, The Robert Robinson Laboratories, University of Liverpool, L69 3BX, Liverpool, UK
| | - Maria C Robertson
- Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, William Henry Duncan Building, 6 West Derby St, Liverpool, L7 8TX, UK; Antimicrobial Drug Discovery and Development, Department of Chemistry, The Robert Robinson Laboratories, University of Liverpool, L69 3BX, Liverpool, UK
| | - Stephen H Prior
- School of Chemistry, Joseph Banks Laboratories, University of Lincoln, Green Lane, Lincoln, LN6 7DL, United Kingdom
| | - Eefjan Breukink
- Department of Membrane Biochemistry and Biophysics, Institute of Biomembranes, Utrecht University, Padualaan 8, 3584, CH, Utrecht, the Netherlands
| | - Annemieke Madder
- Organic and Biomimetic Chemistry Research Group, Department of Organic and Macromolecular Chemistry, Ghent University, Krijgslaan 281 (S4), B-9000, Ghent, Belgium
| | - Ishwar Singh
- Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, William Henry Duncan Building, 6 West Derby St, Liverpool, L7 8TX, UK; Antimicrobial Drug Discovery and Development, Department of Chemistry, The Robert Robinson Laboratories, University of Liverpool, L69 3BX, Liverpool, UK.
| |
Collapse
|
3
|
Brouwer MSM, Goodman RN, Kant A, Mevius D, Newire E, Roberts AP, Veldman KT. Mobile colistin resistance gene mcr-1 detected on an IncI1 plasmid in Escherichia coli from meat. J Glob Antimicrob Resist 2020; 23:145-148. [PMID: 32889139 DOI: 10.1016/j.jgar.2020.08.018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2020] [Accepted: 08/20/2020] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVES Mobile colistin resistance (mcr) genes encoded on conjugative plasmids, although described only relatively recently, have been reported globally both in humans and livestock. The genes are often associated with the insertion sequence ISApl1 that can transpose the genes to novel genetic locations. Since its first report, multiple variants of mcr have been discovered in a variety of genetic locations in Escherichia coli, in plasmids and integrated into the chromosome. METHODS Using hybrid assembly of short-read and long-read whole-genome sequencing data, the presence ofmcr-1 was confirmed on an IncI1 plasmid in E. coli. In vitro conjugation assays were performed to determine the potential to transfer between strains. Genetic comparison with previously reported IncI1 plasmids was performed. RESULTS The genomic sequence identified thatmcr-1 is present on a complete IncI1 plasmid. Comparison with previously reported extended-spectrum β-lactamase (ESBL)-encoding plasmids from E. coli in the Netherlands from the same time period indicated a distinct lineage for this plasmid. CONCLUSIONS The observation ofmcr-1 on an IncI1 plasmid confirms that the genetic region of this gene is actively transposed between genetic locations. This active transposition has consequences for the study of the epidemiology of mcr in populations.
Collapse
Affiliation(s)
| | | | - Arie Kant
- Wageningen Bioveterinary Research, Lelystad, The Netherlands
| | - Dik Mevius
- Wageningen Bioveterinary Research, Lelystad, The Netherlands
| | - Enas Newire
- Institute of Systems, Molecular & Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK
| | | | - Kees T Veldman
- Wageningen Bioveterinary Research, Lelystad, The Netherlands
| |
Collapse
|
4
|
Newire E, Aydin A, Juma S, Enne VI, Roberts AP. Identification of a Type IV-A CRISPR-Cas System Located Exclusively on IncHI1B/IncFIB Plasmids in Enterobacteriaceae. Front Microbiol 2020; 11:1937. [PMID: 32903441 PMCID: PMC7434947 DOI: 10.3389/fmicb.2020.01937] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Accepted: 07/22/2020] [Indexed: 12/15/2022] Open
Abstract
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) are diverse immune systems found in many prokaryotic genomes that target invading foreign DNA such as bacteriophages and plasmids. There are multiple types of CRISPR with arguably the most enigmatic being Type IV. During an investigation of CRISPR carriage in clinical, multi-drug resistant, Klebsiella pneumoniae, a Type IV-A3 CRISPR-Cas system was detected on plasmids from two K. pneumoniae isolates from Egypt (isolated in 2002-2003) and a single K. pneumoniae isolate from the United Kingdom (isolated in 2017). Sequence analysis of all other genomes available in GenBank revealed that this CRISPR-Cas system was present on 28 other plasmids from various Enterobacteriaceae hosts and was never found on a bacterial chromosome. This system is exclusively located on IncHI1B/IncFIB plasmids and is associated with multiple putative transposable elements. Expression of the cas loci was confirmed in the available clinical isolates by RT-PCR. In all cases, the CRISPR-Cas system has a single CRISPR array (CRISPR1) upstream of the cas loci which has several, conserved, spacers which, amongst things, match regions within conjugal transfer genes of IncFIIK/IncFIB(K) plasmids. Our results reveal a Type IV-A3 CRISPR-Cas system exclusively located on IncHI1B/IncFIB plasmids in Enterobacteriaceae that is likely to be able to target IncFIIK/IncFIB(K) plasmids presumably facilitating intracellular, inter-plasmid competition.
Collapse
Affiliation(s)
- Enas Newire
- UCL Eastman Dental Institute, University College London, London, United Kingdom
| | - Alp Aydin
- Centre for Clinical Microbiology, Royal Free Hospital, University College London, London, United Kingdom
| | - Samina Juma
- Centre for Clinical Microbiology, Royal Free Hospital, University College London, London, United Kingdom
| | - Virve I. Enne
- Centre for Clinical Microbiology, Royal Free Hospital, University College London, London, United Kingdom
| | - Adam P. Roberts
- Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
- Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
| |
Collapse
|
5
|
Hubbard ATM, Newire E, Botelho J, Reiné J, Wright E, Murphy EA, Hutton W, Roberts AP. Isolation of an antimicrobial-resistant, biofilm-forming, Klebsiella grimontii isolate from a reusable water bottle. Microbiologyopen 2020; 9:1128-1134. [PMID: 32126585 PMCID: PMC7294305 DOI: 10.1002/mbo3.1023] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2019] [Revised: 01/31/2020] [Accepted: 02/14/2020] [Indexed: 12/14/2022] Open
Abstract
A reusable water bottle was swabbed as part of the citizen science project "Swab and Send," and a Klebsiella grimontii isolate was recovered on chromogenic agar and designated SS141. Whole-genome sequencing of SS141 showed it has the potential to be a human pathogen as it contains the biosynthetic gene cluster for the potent cytotoxin, kleboxymycin, and genes for other virulence factors. The genome also contains the antibiotic-resistant genes, blaOXY-6-4 , and a variant of fosA, which is likely to explain the observed resistance to ampicillin, amoxicillin, and fosfomycin. We have also shown that SS141 forms biofilms on both polystyrene and polypropylene surfaces, providing a reasonable explanation for its ability to colonize a reusable water bottle. With the increasing use of reusable water bottles as an alternative to disposables and a strong forecast for growth in this industry over the next decade, this study highlights the need for cleanliness comparable to other reusable culinary items.
Collapse
Affiliation(s)
- Alasdair T M Hubbard
- Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Enas Newire
- School of Pharmacy, College of Science, University of Lincoln, Lincoln, UK
| | - João Botelho
- Antibiotic Resistance Evolution Group, Max-Planck-Institute for Evolutionary Biology, Plön, Germany.,Department of Evolutionary Ecology and Genetics, Zoological Institute, Christian-Albrechts-Universität zu Kiel, Kiel, Germany
| | - Jesús Reiné
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Elli Wright
- Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Emma A Murphy
- Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK
| | - William Hutton
- Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Adam P Roberts
- Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK
| |
Collapse
|
6
|
Aydin S, Personne Y, Newire E, Laverick R, Russell O, Roberts AP, Enne VI. Presence of Type I-F CRISPR/Cas systems is associated with antimicrobial susceptibility in Escherichia coli. J Antimicrob Chemother 2017; 72:2213-2218. [DOI: 10.1093/jac/dkx137] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2016] [Accepted: 04/11/2017] [Indexed: 01/19/2023] Open
|